$50.67
-1.48 (-2.84%)
At Close: Jun 18, 2026
Why GSK (GSK) is a Top Growth Stock for the Long-Term
10:45am, Thursday, 09'th Oct 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:51am, Tuesday, 07'th Oct 2025
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
My Top 5 Biotech Stocks Big Pharma Could Buy Next
01:29pm, Monday, 06'th Oct 2025
While AI hype reigns on Wall Street, the healthcare sector is still far from the peaks it reached during the COVID-19 pandemic. And what's more important, many of the biotech stocks remain outside of
Focus: US Health Secretary Kennedy speeds autism drug with GSK help
06:02am, Monday, 06'th Oct 2025
U.S. Health Secretary Robert F Kennedy Jr. could deliver a policy win for the Trump administration in just a few months after the Food and Drug Administration enlisted GSK to help it fast-track approv
Will Glaxo (GSK) Beat Estimates Again in Its Next Earnings Report?
01:11pm, Friday, 03'rd Oct 2025
Glaxo (GSK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why GSK (GSK) is a Top Value Stock for the Long-Term
10:41am, Thursday, 02'nd Oct 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
New Local Data in GSK and IQVIA's Vaccine Track Supports Smarter Public Health Action at the Community Level
10:00am, Wednesday, 01'st Oct 2025
PHILADELPHIA--(BUSINESS WIRE)-- #AdultVaccination--GSK plc (LSE/NYSE: GSK) today announced a major update to Vaccine Track, a first-of-its-kind, interactive public data tool for tracking adult immuniz
GSK names Luke Miels as next CEO after Emma Walmsley steps down; shares jump
10:02am, Tuesday, 30'th Sep 2025
GSK announced on Monday that Chief Executive Emma Walmsley will step down after nine years in the role, with current Chief Commercial Officer Luke Miels set to take over on January 1. The transition m
Emma Walmsley To Step Down As GSK CEO After Nine Years, Luke Miels To Lead Starting January 2026
10:00am, Monday, 29'th Sep 2025
GSK plc (NYSE: GSK) appointed Luke Miels as the CEO Designate of GSK. He will assume full responsibility as CEO and join the Board on January 1, 2026.
GSK Leaps Into Buy Zone On Surprise Departure Of CEO Emma Walmsley
09:15am, Monday, 29'th Sep 2025
GSK stock jumped back into a buy zone Monday after announcing Chief Executive Emma Walmsley will step down at the end of the year.
GSK turns to insider to be next CEO — and the stock rallies
04:46am, Monday, 29'th Sep 2025
Shares of U.K. pharmaceutical giant GSK rallied on Monday after it turned to an insider to become its next CEO.
GSK names Luke Miels as next CEO after Emma Walmsley steps down; shares jump
03:59am, Monday, 29'th Sep 2025
GSK announced on Monday that Chief Executive Emma Walmsley will step down after nine years in the role, with current Chief Commercial Officer Luke Miels set to take over on January 1. The transition m
GSK chief exec Emma Walmsley to leave in January
02:42am, Monday, 29'th Sep 2025
GSK PLC (LSE:GSK, NYSE:GSK) chief executive Dame Emma Walmsley will step down from 1 January next year after almost nine years in the role. The pharmaceutical group has promoted its chief commercia
GSK names Luke Miels as CEO designate
02:07am, Monday, 29'th Sep 2025
British drugmaker GSK said on Monday it has appointed Luke Miels as CEO designate and he will assume full responsibilities as chief executive on January 1, 2026.
GSK plc (GSK) plc Presents at Bank of America Global Healthcare Conference 2025 Transcript
09:43am, Wednesday, 24'th Sep 2025
GSK plc (NYSE:GSK ) plc Bank of America Global Healthcare Conference 2025 September 24, 2025 4:00 AM EDT Company Participants Julie Brown - CFO & Executive Director Tony Wood - Chief Scientific Office
Sign In
Buy GSK